Clinical Trial Update: Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing ketamine binding to the serotonin transporter using positron emission tomography in depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Medical University of Vienna | Conditions: Depression, Ketamine | Phase 2 | Status: UNKNOWN